Question:

Favipiravir tested as a COVID-19 treatment is a product of which company?

Show Hint

RNA polymerase inhibitors like favipiravir target viral replication, making them essential in antiviral drug development.
Updated On: Jun 8, 2025
  • \( \text{Fujifilms} \)
  • \( \text{AstraZeneca} \)
  • \( \text{Safoni team} \)
  • \( \text{Takeda} \)
Hide Solution
collegedunia
Verified By Collegedunia

The Correct Option is A

Solution and Explanation

Favipiravir, originally developed by Fujifilm Toyama Chemical, is an antiviral drug investigated for treating COVID-19. It functions as a RNA-dependent RNA polymerase inhibitor, disrupting viral replication. Favipiravir was initially designed for influenza but gained attention during the pandemic for its potential antiviral efficacy.
Was this answer helpful?
0
0